Epicutaneous immunization with myelin basic protein protects from the experimental autoimmune encephalomyelitis

Pharmacological Reports

Volumn 59, Issue 1, 2007, Pages 74-79

  Majewska, Monika ^a   Zajac, Katarzyna ^a   Srebro, Zbigniew ^a   Sura, Piotr ^a   Ksiazek, Lucyna ^a   Zemelka, Magdalena ^a   Szczepanik, Marian ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Epicutaneous immunization; Experimental autoimmune encephalomyelitis; Myelin basic protein; Suppression

Indexed keywords

MYELIN BASIC PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL ISOLATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; EPICUTANEOUS DRUG ADMINISTRATION; FEMALE; HISTOLOGY; IMMUNIZATION; MONONUCLEAR CELL; MOUSE; NEUROPROTECTION; NONHUMAN; PROTECTION; RELAPSE; REMISSION; SPINAL CORD;

EID: 34047111351     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Benson, JM, Stuckman SS, Cox KL, Wardrop RM, Gienapp IE, Cross AH, Trotter JL, Whitacre CC: Oral administration of myelin basic protein is superior to myelin in suppressing established relapsing experimental autoimmune encephalomyelitis. J Immunol, 1999, 162, 6247-6254.
2. Chen Y, Inobe J, Kuchroo VK, Baron JL, Janeway CA Jr, Weiner HL: Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci USA, 1996, 93, 388-399.
3. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific Transforming Growth Factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest, 1996, 98, 70-77.
4. Hemmer B, Cepok S, Nessler S. Sommer N: Pathogenesis of multiple sclerosis: an update on immunology. Curr Opin Neurol, 2002, 15, 227-231.
5. Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K: Th2 responses induced by epicuteneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest, 2000, 105, 765-775.
6. Higgins PJ, Weiner HL: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol, 1988, 140, 440-445.
7. Inobe J, Slavin AJ, Komagata Y, Chan Y, Liu L, Weiner HL: IL-4 is a differentiation factor for Transforming Growth Factor-β secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur J Immunol, 1998, 28, 2780-2790.
8. Majewska M, Zajac K, Kubera M, Bryniarski K, Ptak M, Basta-Kaim A, Ksiaιzek L et al.: Effects of ovalbumin on survival of H-Y incompatible skin graft in C57B1/6 mice. Pharmacol Rep, 2006, 58, 439-442.
9. Mitchison NA, Schuhbauer D, Müller B: Natural and induced regulation of Th1/Th2 balance. Springer Semin Immunopathol, 1999, 21, 199-200.
10. Pearse AGE: Histochemistry, Theoretical and Applied. Churchill, Loondon, 1960.
11. Ptak W. Szczepanik M, Bryniarski K, Tutaj M, Ptak M: Epicutaneous application of protein antigens incorporated into cosmatic cream induces antigen-nonspecific unresponsiveness in mice and affects the cell-mediated immune response. Int Arch Allergy Immunol, 2002, 128, 8-14.
12. Sheehan DC, Hrapchak BB: Theory and Practice of Histotechnology 2nd edn, Columbus Battelle Press, Ohio, 1980.
13. Shreedhar VK, Pride MW, Sun Y, Kripke ML, Strickland FM: Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes. J Immunol, 1998, 161, 1327-1335.
14. Stinissen P, Raus J, Zhang J: Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol, 1997, 17, 33-75.
15. Szczepanik M: Skin-induced tolerance and its clinical implications. Modern Amp Immunobiol, 2002, 2, 265-268.
16. Szczepanik M, Bryniarski K, Tutaj M, Ptak M, Skrzeczynska J, Askenase PW, Ptak W: Epicutaneous immunization induces αβ T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-β. Immunology, 2005, 115, 42-54.
17. Szczepanik M, Tutaj M, Bryniarski K, Dittel BN: Epicutaneously induced TGF-β-dependent tolerance inhibits experimental autoimmune encephalomyelitis. J Neuroimmunol, 2005, 164, 105-114.
18. Wang LF, Lin JY, Hsieh KH, Lin RH: Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol, 1996, 156, 4077-4082.
19. Wiendl H, Hohlfeld R: Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials. BioDrugs, 2002, 16, 183-200.
20. Xiao BG, Link H: Mucosal tolerance: a two-edged sword to prevent and treat autoimmune disease. Clin Immunol Immunopathol, 1997, 85, 119-128.